The contract drug manufacturer's deal for closely held Bettera would expand Catalent's manufacturing capabilities for vitamin, minerals and supplements to make them in gummy form.
Catalent to Buy Supplement Maker Bettera Holdings for $1 Billion
Wall Street Journal - 30 Aug 2021 01:12
The contract drug manufacturer's deal for closely held Bettera would expand Catalent's manufacturing capabilities for vitamin, minerals and supplements to make them in gummy form.
Share this Article
Recommended